Myriad Genetics' (MYGN) New Platform to Advance Cancer Care
https://www.zacks.com/stock/news/2201001/myriad-genetics-mygn-new-platform-to-advance-cancer-care?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2201001
Dec 21, 2023 - Myriad Genetics' (MYGN) new MCRR platform advances patient care by combining structured clinical data with genetic and genomic results.
0
Bruker (BRKR) Installs First 1.2 GHz NMR at Ohio University
https://www.zacks.com/stock/news/2200633/bruker-brkr-installs-first-1-2-ghz-nmr-at-ohio-university?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2200633
Dec 20, 2023 - Bruker (BRKR) 1.2 GHz AVANCE NMR spectrometer is cutting-edge equipment capable of performing high-resolution liquid and solid-state NMR studies.
0
Venus Concept (VERO) Expands Global Reach With New Partnerships
https://www.zacks.com/stock/news/2200464/venus-concept-vero-expands-global-reach-with-new-partnerships?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2200464
Dec 20, 2023 - Venus Concept (VERO) expects its deals to fetch continued success in both the United Kingdom and India.
0
DexCom's (DXCM) G7 CGM Connects With Tandem's Insulin Pump
https://www.zacks.com/stock/news/2200159/dexcom-s-dxcm-g7-cgm-connects-with-tandem-s-insulin-pump?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2200159
Dec 19, 2023 - Dexcom's (DXCM) G7 integrates with Tandem's t:slim X2, revolutionizing diabetes care. A perfect combination of accuracy and innovation, this synergy sets a new standard in continuous glucose monitoring.
0
Masimo's (MASI) Stork Baby Monitoring System Approved by FDA
https://www.zacks.com/stock/news/2200083/masimo-s-masi-stork-baby-monitoring-system-approved-by-fda?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2200083
Dec 19, 2023 - The latest FDA clearance of Masimo's (MASI) Stork smart home baby monitoring system is likely to provide a continuous and accurate view of babies' health data.
0
Here's Why You Should Invest in Penumbra (PEN) Stock Now
https://www.zacks.com/stock/news/2200052/here-s-why-you-should-invest-in-penumbra-pen-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2200052
Dec 19, 2023 - Investors are optimistic about Penumbra (PEN), which is led by growth in vascular and neuro businesses.
0
CVS Health (CVS) New Opportunities Drive Growth, Macro Woes Stay
https://www.zacks.com/stock/news/2199865/cvs-health-cvs-new-opportunities-drive-growth-macro-woes-stay?cid=CS-ZC-FT-analyst_blog|zer_report_update-2199865
Dec 19, 2023 - CVS Health's (CVS) restructuring plan poises it well, along with its strategic buyouts.
0
SenesTech (SNES) Likely to Expand Into China With New Deal
https://www.zacks.com/stock/news/2199856/senestech-snes-likely-to-expand-into-china-with-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2199856
Dec 19, 2023 - This partnership provides SenesTech (SNES) with a gateway into one of the largest pest control markets globally, with the support and expertise of Fruit Tree.
0
Charles River's (CRL) Memphis Site Achieves Crucial Approval
https://www.zacks.com/stock/news/2199833/charles-river-s-crl-memphis-site-achieves-crucial-approval?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2199833
Dec 19, 2023 - Charles River (CRL) reaches an important milestone in cell therapy manufacturing collaboration with Vertex Pharmaceuticals.
0
Here's Why You Should Retain Tandem Diabetes (TNDM) Now
https://www.zacks.com/stock/news/2199822/here-s-why-you-should-retain-tandem-diabetes-tndm-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2199822
Dec 19, 2023 - Investors remain optimistic about Tandem Diabetes (TNDM), backed by the impressive spree of product introductions.
0